HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
About this study
This randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The community-delivered hearing care intervention utilizes tailored strategies to assess impact on communication, neuropsychiatric symptoms (NPS), and care partner distress.
- Condition
- Alzheimer Disease, Dementia, Hearing Loss, Cognitive Impairment
- Tested
- HEARS-NPS device, HEARS-NPS program
- Sponsor
- Johns Hopkins University
Who can join
- Age
- 60 to 100 years
- Sex
- All sexes
- Healthy volunteers
- Accepted
Inclusion 9
- Minimum age: 60 years
- Maximum age: 100 years
- Study condition: Alzheimer Disease, Dementia, Hearing Loss, Cognitive Impairment
- Age 60 - 100 years old
- English-speaking
- Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
- Speech frequency pure tone average (0.5- 4 kHz) \>25 db in the better-hearing ear; adult onset hearing loss
- Availability of caregiver/study partner who is 18+ to participate in all study-related visits and who provides care supervision
- Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms
Exclusion 3
- Current self-reported use of hearing aid or amplification device
- Medical contraindication to use hearing aids ( e.g. draining ears)
- Inability to participate in the 1-month follow up
Where
1 site, 1 recruiting
Johns Hopkins Memory and Alzheimer's Treatment Center
Baltimore, Maryland, United States
Contact
-
Esther Oh, MD, Ph.D.
410-550-0925 eoh9@jhmi.edu
-
Jami Trumbo, MSPH
Potential match only. Final eligibility is determined by the study team.